Management of Latent Tuberculosis Infection in Healthcare Workers

Diagnostic Confirmation

The Centers for Disease Control and Prevention recommends that a PPD induration of 12 mm exceeds the 10 mm threshold for healthcare workers, who are considered a high-risk group for TB exposure 1, 2
Normal clinical examination and laboratory tests rule out active TB disease, which must be excluded before initiating LTBI treatment, according to the Centers for Disease Control and Prevention 1, 2
The World Health Organization guidelines require systematic testing and treatment for LTBI in healthcare workers in low TB burden countries 3

The Centers for Disease Control and Prevention recommends 9-month isoniazid as the standard treatment regimen for LTBI in healthcare workers and other high-risk populations 1, 2, 4
Prospective randomized trials demonstrate that 9 months provides maximal benefit compared to 6 months, with subgroup analyses showing optimal protection achieved by 9 months, as reported by the Centers for Disease Control and Prevention 4

The World Health Organization recognizes several acceptable alternatives for LTBI treatment, including 3-4 months of rifampin alone, 3-4 months of isoniazid plus rifampin, and 3 months of weekly rifapentine plus isoniazid, with strong recommendations and moderate to high quality evidence 3, 5
Rifampin-based regimens have fewer hepatotoxicity events compared to isoniazid regimens, with an odds ratio of 0.03 and 95% CI 0.00-0.48 for 3-4 month rifampin vs 6-month isoniazid, as reported by the European Respiratory Society 5

The Centers for Disease Control and Prevention recommends monthly clinical evaluations during isoniazid therapy, including assessment for symptoms of hepatitis and patient education to stop treatment and seek immediate evaluation if symptoms occur 1, 2, 6
Baseline liver function tests are not routinely required for healthy healthcare workers under age 35, but are indicated for those with HIV infection, pregnant or immediate postpartum women, history of chronic liver disease, regular alcohol use, or concurrent hepatotoxic medications, as recommended by the Centers for Disease Control and Prevention 1, 2, 6

The Centers for Disease Control and Prevention advises against withholding treatment based on age alone in healthcare workers with positive PPD tests, as they are at ongoing risk for TB exposure regardless of age 1, 7
The Centers for Disease Control and Prevention recommends against using multi-drug regimens for LTBI, as this is inappropriate and exposes patients to unnecessary toxicity 1
The European Respiratory Society advises against accepting 3-month isoniazid monotherapy, as this duration is inadequate for LTBI treatment 1, 5
The Centers for Disease Control and Prevention recommends ruling out active TB before starting LTBI treatment through history, physical examination, and chest radiography 1, 2, 6